| TSC1 | TSC2 | P value |
---|---|---|---|
(n = 21) | (n = 107) | TSC1 versus TSC2 | |
Age (years), median (range) | 30 (6–54) | 31 (4–59) | 0.37 |
Sex | Â | Â | 0.031 |
 Male | 4 | 48 |  |
 Female | 17 | 59 |  |
Familial/de novo | Â | Â | 0.015 |
 Familial | 6 | 10 |  |
 De novo | 15 | 97 |  |
Major criteria | Â | Â | Â |
 Angiofibromas (≥ 3) or forehead | 14/21 | 88/107 | 0.10 |
 Hypomelanotic macules (≥ 3) | 15/21 | 85/107 | 0.42 |
 Ungual fibromas (≥ 2) | 7/21 | 57/107 | 0.095 |
 Chagrin patch | 10/21 | 61/107 | 0.42 |
 Multiple retinal hamartomas | 3/15 | 11/81 | 0.45 |
 Cortical dysplasia | 2/21 | 12/107 | 0.99 |
 SEN | 20/21 | 86/107 | 0.12 |
 SEGA | 1/21 | 4/104 | 0.99 |
 Cardiac rhabdomyoma | 3/19 | 5/102 | 0.11 |
 LAM (women) | 6/18 | 26/105 | 0.064 |
 Renal AML (≥ 2) | 20/21 | 103/107 | 0.99 |
Minor criteria | Â | Â | Â |
 Confetti skin lesions | 3/21 | 19/107 | 0.99 |
 Dental enamel pits (≥ 3) | 5/21 | 15/106 | 0.27 |
 Intraoral fibromas (≥ 2) | 2/21 | 12/106 | 0.99 |
 Retinal achromatic patch | 0/14 | 0/76 | – |
 Non-renal hamartomas | 5/20 | 22/105 | 0.69 |
 Multiple renal cysts | 1/20 | 12/106 | 0.69 |